Expert review of clinical pharmacology

Keyphrases

Publications

2023

Gabrielle J Widjaja, Danijela Gnjidic, Alexander J Clough, Karen Watson, Kenneth W Hepburn, Mouna J Sawan
Availability and evaluation of medication management resources for carers of people with dementia: a scoping review with an environmental scan. Expert review of clinical pharmacology (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology (2023)
Georgios Polychronopoulos, Achilleas Papagiannis, Konstantinos Tziomalos
Strategies for lowering lipoprotein(a): a spotlight on novel pharmacological treatments. Expert review of clinical pharmacology (2023)

volume 16, number 1, 2023

Harmanjit Singh, Jasbir Singh, Ravneet Kaur Bhangu, Mandeep Singla, Jagjit Singh, Farideh Javid
Potential approaches using teneligliptin for the treatment of type 2 diabetes mellitus: current status and future prospects. Expert review of clinical pharmacology 16 (1) (2023)
Harmanjit Singh, Jasbir Singh, Ravneet Kaur Bhangu, Mandeep Singla, Jagjit Singh, Farideh Javid
Potential approaches using teneligliptin for the treatment of type 2 diabetes mellitus: current status and future prospects. Expert review of clinical pharmacology 16 (1) (2023)

volume 16, number 2, 2023

Thomas Müller, Peter Riederer, Wilfried Kuhn
Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome? Expert review of clinical pharmacology 16 (2) (2023)
Ariana Moreno, Yael Renert-Yuval, Emma Guttman-Yassky
Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis. Expert review of clinical pharmacology 16 (2) (2023)
Maria Velliou, Effie Polyzogopoulou, Ioannis Ventoulis, John Parissis
Clinical pharmacology of SGLT-2 inhibitors in heart failure. Expert review of clinical pharmacology 16 (2) (2023)
Ariana Moreno, Yael Renert-Yuval, Emma Guttman-Yassky
Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis. Expert review of clinical pharmacology 16 (2) (2023)
Georgios Polychronopoulos, Achilleas Papagiannis, Konstantinos Tziomalos
Strategies for lowering lipoprotein(a): a spotlight on novel pharmacological treatments. Expert review of clinical pharmacology 16 (2) (2023)
Zhen Ruan, Yixuan Jiang, Honghao Shi, Ruxu Jia, Carolina Oi Lam Ung, Hao Hu
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review. Expert review of clinical pharmacology 16 (2) (2023)
Xiao Yu, H Karl Greenblatt, David J Greenblatt
Designer benzodiazepines: an update. Expert review of clinical pharmacology 16 (2) (2023)
Maria Velliou, Effie Polyzogopoulou, Ioannis Ventoulis, John Parissis
Clinical pharmacology of SGLT-2 inhibitors in heart failure. Expert review of clinical pharmacology 16 (2) (2023)
Ariana Moreno, Yael Renert-Yuval, Emma Guttman-Yassky
Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis. Expert review of clinical pharmacology 16 (2) (2023)
Zhen Ruan, Yixuan Jiang, Honghao Shi, Ruxu Jia, Carolina Oi Lam Ung, Hao Hu
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review. Expert review of clinical pharmacology 16 (2) (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology 16 (2) (2023)
Georgios Polychronopoulos, Achilleas Papagiannis, Konstantinos Tziomalos
Strategies for lowering lipoprotein(a): a spotlight on novel pharmacological treatments. Expert review of clinical pharmacology 16 (2) (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology 16 (2) (2023)
Thomas Müller, Peter Riederer, Wilfried Kuhn
Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome? Expert review of clinical pharmacology 16 (2) (2023)
Xiao Yu, H Karl Greenblatt, David J Greenblatt
Designer benzodiazepines: an update. Expert review of clinical pharmacology 16 (2) (2023)

volume 16, number 3, 2023

Dario Cattaneo, Deborah Je Marriott, Cristina Gervasoni
Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations. Expert review of clinical pharmacology 16 (3) (2023)
Zhiwei Zheng, Gaofeng Zhu, Xueqiong Cao, Hongfu Cai, Huide Zhu
A cost-effectiveness analysis of first-line toripalimab plus chemotherapy in advanced nonsquamous non-small cell lung cancer in China. Expert review of clinical pharmacology 16 (3) (2023)
Fabian Olsson, Simon Erridge, James Tait, Carl Holvey, Ross Coomber, Sushil Beri, Jonathan Hoare, Shaheen Khan, Mark W Weatherall, Michael Platt, James J Rucker, Mikael Hans Sodergren
An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry. Expert review of clinical pharmacology 16 (3) (2023)
Jessica A Spiteri, Gabrielle Camilleri, Carlo Piccinni, Salvatore Crisafulli
Safety of drugs used for the treatment of migraine during pregnancy: a narrative review. Expert review of clinical pharmacology 16 (3) (2023)
Zhiwei Zheng, Gaofeng Zhu, Xueqiong Cao, Hongfu Cai, Huide Zhu
A cost-effectiveness analysis of first-line toripalimab plus chemotherapy in advanced nonsquamous non-small cell lung cancer in China. Expert review of clinical pharmacology 16 (3) (2023)
Andrea Marchetti, Elisa Tassinari, Matteo Rosellini, Alessandro Rizzo, Francesco Massari, Veronica Mollica
Prostate cancer and novel pharmacological treatment options-what's new for 2022? Expert review of clinical pharmacology 16 (3) (2023)
Fabian Olsson, Simon Erridge, James Tait, Carl Holvey, Ross Coomber, Sushil Beri, Jonathan Hoare, Shaheen Khan, Mark W Weatherall, Michael Platt, James J Rucker, Mikael Hans Sodergren
An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry. Expert review of clinical pharmacology 16 (3) (2023)
Xiaoyu Sun, Suying Xu, Yiming Li, Xuemei Lv, Min-Jie Wei, Miao He
Efficacy and safety of PARP inhibitors in the treatment of BRCA-mutated breast cancer: an updated systematic review and meta-analysis of randomized controlled trials. Expert review of clinical pharmacology 16 (3) (2023)
Gianluca Sesso, Gabriele Masi
Pharmacological strategies for the management of the antisocial personality disorder. Expert review of clinical pharmacology 16 (3) (2023)
Jonathan G Leung, Megan Ehret, Raymond C Love, Robert O Cotes
Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues. Expert review of clinical pharmacology 16 (3) (2023)
Xiaoyu Sun, Suying Xu, Yiming Li, Xuemei Lv, Min-Jie Wei, Miao He
Efficacy and safety of PARP inhibitors in the treatment of BRCA-mutated breast cancer: an updated systematic review and meta-analysis of randomized controlled trials. Expert review of clinical pharmacology 16 (3) (2023)
Andrea Marchetti, Elisa Tassinari, Matteo Rosellini, Alessandro Rizzo, Francesco Massari, Veronica Mollica
Prostate cancer and novel pharmacological treatment options-what's new for 2022? Expert review of clinical pharmacology 16 (3) (2023)
Gianluca Sesso, Gabriele Masi
Pharmacological strategies for the management of the antisocial personality disorder. Expert review of clinical pharmacology 16 (3) (2023)
Dario Cattaneo, Deborah Je Marriott, Cristina Gervasoni
Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations. Expert review of clinical pharmacology 16 (3) (2023)
Jessica A Spiteri, Gabrielle Camilleri, Carlo Piccinni, Salvatore Crisafulli
Safety of drugs used for the treatment of migraine during pregnancy: a narrative review. Expert review of clinical pharmacology 16 (3) (2023)
Gabrielle J Widjaja, Danijela Gnjidic, Alexander J Clough, Karen Watson, Kenneth W Hepburn, Mouna J Sawan
Availability and evaluation of medication management resources for carers of people with dementia: a scoping review with an environmental scan. Expert review of clinical pharmacology 16 (3) (2023)
Jonathan G Leung, Megan Ehret, Raymond C Love, Robert O Cotes
Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues. Expert review of clinical pharmacology 16 (3) (2023)
Gabrielle J Widjaja, Danijela Gnjidic, Alexander J Clough, Karen Watson, Kenneth W Hepburn, Mouna J Sawan
Availability and evaluation of medication management resources for carers of people with dementia: a scoping review with an environmental scan. Expert review of clinical pharmacology 16 (3) (2023)

volume 16, number 5, 2023

Gema Ariceta
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Expert review of clinical pharmacology 16 (5) (2023)
Rosanna Ruggiero, Raffaella Di Napoli, Nunzia Balzano, Donatella Ruggiero, Consiglia Riccardi, Antonietta Anatriello, Andrea Cantone, Liberata Sportiello, Francesco Rossi, Annalisa Capuano
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management. Expert review of clinical pharmacology 16 (5) (2023)
Vera Battini, Giovanna Cirnigliaro, Luca Giacovelli, Maria Boscacci, Silvia Massara Manzo, Giulia Mosini, Greta Guarnieri, Michele Gringeri, Beatrice Benatti, Emilio Clementi, Bernardo Dell'Osso, Carla Carnovale
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS. Expert review of clinical pharmacology 16 (5) (2023)
Gema Ariceta
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Expert review of clinical pharmacology 16 (5) (2023)
Alan L Myers, Arthur H Jeske
Provider-directed analgesia for dental pain. Expert review of clinical pharmacology 16 (5) (2023)
Alan L Myers, Arthur H Jeske
Provider-directed analgesia for dental pain. Expert review of clinical pharmacology 16 (5) (2023)
Gema Ariceta
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Expert review of clinical pharmacology 16 (5) (2023)
Vera Battini, Giovanna Cirnigliaro, Luca Giacovelli, Maria Boscacci, Silvia Massara Manzo, Giulia Mosini, Greta Guarnieri, Michele Gringeri, Beatrice Benatti, Emilio Clementi, Bernardo Dell'Osso, Carla Carnovale
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS. Expert review of clinical pharmacology 16 (5) (2023)
Rosanna Ruggiero, Raffaella Di Napoli, Nunzia Balzano, Donatella Ruggiero, Consiglia Riccardi, Antonietta Anatriello, Andrea Cantone, Liberata Sportiello, Francesco Rossi, Annalisa Capuano
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management. Expert review of clinical pharmacology 16 (5) (2023)
Rosanna Ruggiero, Raffaella Di Napoli, Nunzia Balzano, Donatella Ruggiero, Consiglia Riccardi, Antonietta Anatriello, Andrea Cantone, Liberata Sportiello, Francesco Rossi, Annalisa Capuano
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management. Expert review of clinical pharmacology 16 (5) (2023)
Vera Battini, Giovanna Cirnigliaro, Luca Giacovelli, Maria Boscacci, Silvia Massara Manzo, Giulia Mosini, Greta Guarnieri, Michele Gringeri, Beatrice Benatti, Emilio Clementi, Bernardo Dell'Osso, Carla Carnovale
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS. Expert review of clinical pharmacology 16 (5) (2023)
Alan L Myers, Arthur H Jeske
Provider-directed analgesia for dental pain. Expert review of clinical pharmacology 16 (5) (2023)